LifeArc funds COVID-19 drug screening hub at the University of Glasgow

A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University…

LifeArc co-leads £6 million funding in DJS Antibodies

LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the…

LifeArc and Cleveland Clinic collaborate to advance early stage research towards patients

LifeArc to fund two post-doctoral fellowships focused on drug discovery In November 2020, LifeArc initiated a new…

KQ Labs Accelerator welcomes 10 innovative start-ups

London, UK - KQ Labs, an accelerator programme focused on data-driven health, run by the Francis Crick…

UK DRI appoints LifeArc to support translation of discoveries into treatments

LifeArc has been appointed by the UK Dementia Research Institute (UK DRI) to provide expertise to accelerate…

LifeArc and Future Fund provide £3.0m in funding to Avvinity Therapeutics

Funding to help drive the development of new cancer therapies

Biocartis expands collaboration with LifeArc

Mechelen, Belgium, and London, UK, 1 September 2020 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an…

LifeArc appoints Dr Ian Campbell as Chief Business Officer

Former Innovate UK Executive Chair joins charity to drive new collaborations and partnerships to benefit patient health.

LifeArc appoints Clare Terlouw to lead its life sciences investment strategy

Clare will be responsible for LifeArc’s investments across the life science sector